**Chapter 7**

*Human Microbiome*

2014;**93**(8):e51

2015;**149**(1):102-109

2015;**149**(1):110-118

[38] Rossen NG, Fuentes S, van der Spek MJ, et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology.

[39] Cammarota G, Ianiro G, Gasbarrini A. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: A systematic review. Journal of Clinical Gastroenterology. 2014;**48**(8):693-702

[40] Youngster I, Russell GH, Pindar C, Ziv-Baran T, Sauk J, Hohmann EL. Oral, capsulized, frozen fecal microbiota transplantation for relapsing

Clostridium difficile infection. Journal of the American Medical Association.

[41] Li YT, Cai HF, Wang ZH, Xu J, Fang JY. Systematic review with metaanalysis: Long-term outcomes of

2014;**312**(17):1772-1778

[34] Costello SP, Tucker EC, La Brooy J, Schoeman MN, Andrews JM. Establishing a fecal microbiota

transplant service for the treatment of Clostridium difficile infection. Clinical Infectious Diseases. 2016;**62**(7):908-914 faecal microbiota transplantation for Clostridium difficile infection. Alimentary Pharmacology & Therapeutics. 2016;**43**(4):445-457

[42] Zhang F, Cui B, He X, et al. Microbiota transplantation: Concept, methodology and strategy for its modernization. Protein & Cell.

[43] Suskind DL, Brittnacher MJ, Wahbeh G, et al. Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease. Inflammatory Bowel Diseases.

[44] Vaughn BP, Gevers D, Ting A, Korzenik JR, Robson SC, Moss AC. Fecal microbiota transplantation induces early improvement in symptoms in patients with active Crohn's disease. Gastroenterology. 2014;**146**(5 suppl 1):

[45] Cui B, Feng Q, Wang H, et al. Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: Safety, feasibility, and efficacy trial results. Journal of Gastroenterology and

Hepatology. 2015;**30**(1):51-58

2018;**9**(5):462-473

2015;**21**(3):556-563

S591-S592

[35] Chen L, Wang W, Zhou R, et al. Characteristics of fecal and mucosaassociated microbiota in Chinese patients with inflammatory bowel disease. Medicine (Baltimore).

[36] Kelly CR, Khoruts A, Staley C, et al. Effect of fecal microbiota transplantation on recurrence in multiply recurrent Clostridium difficile infection: A randomized trial. Annals of Internal Medicine. 2016;**165**(9):609-616

[37] Moayyedi P, Surette MG, Kim PT, et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology.

**138**
